Stay updated on Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4 on the page; this reflects a small backend update to the document revision metadata.
    Difference
    0.0%
    Check dated 2026-07-25T11:35:59.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a newer page revision. This update appears to be a versioning change rather than a modification to the study details or content.
    Difference
    0.0%
    Check dated 2026-07-03T21:53:43.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    Page build version updated from v3.6.0 to v3.6.2, indicating a newer release of the study page. This update appears to be an underlying site/framework change rather than a modification to the reported trial details.
    Difference
    0.0%
    Check dated 2026-06-26T23:49:31.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Recruitment status updated to no longer enrolling participants, and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) are added while the Intervention/Treatment heading is updated and the page shows Revision: v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:35:34.000Z thumbnail image
  8. Check
    61 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.5.4 to v3.5.5 in the footer, indicating a new site release.
    Difference
    0.0%
    Check dated 2026-06-05T12:54:09.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    The Publications section no longer lists a previously cited study (CheckMate 038 immunomodulatory effects). This reduces the number of references linked to this trial record.
    Difference
    0.0%
    Check dated 2026-05-29T08:56:33.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Metastatic Cancer Clinical Trial page.